Heart Disease Trial, Recruiting NCT05961488 Sponsor: CHU de Reims Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT05961488
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been admitted to an intensive care unit after their heart stopped outside of a hospital and was successfully restarted
  • People where no clear cause for the cardiac arrest has been found after reviewing their medical history, a brain scan, and a lung blood vessel scan
  • People who do not have a specific type of heart attack involving a pattern called ST elevation on their heart tracing

Who may not be able to join:

  • People whose heart stopped while already in a hospital
  • People whose heart could not be restarted despite resuscitation attempts
  • People who need an immediate procedure to look at their heart's arteries
  • People who have a type of heart attack showing ST elevation, or an uncertain abnormal electrical pattern in the heart
  • People showing new or changing abnormal patterns on their heart tracing
  • People whose heart is too weak to pump enough blood around the body
  • People with dangerous irregular heart rhythms
  • People who have previously had heart bypass surgery
  • People who are pregnant
  • People whose multiple organs are failing at the same time
  • People with known severe long-term kidney disease (where kidney function is significantly reduced)
  • People who develop blood pressure instability requiring high doses of a blood pressure medication called norepinephrine during a specific heart scan procedure
  • People who have an irregular heart rhythm (not a normal sinus rhythm) at the time of the heart scan procedure
  • People who develop a certain level of sudden kidney injury (confirm with trial site) during the heart scan procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 03 10 73 68 85

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
CHU de Reims
Registry
ClinicalTrials.gov
Start date
4 March 2024
Est. completion
1 June 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Diagnostic accuracy of Coronary Computerized Tomographic Angiogram to rule-out a coronary stenosis > 50%

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov